Showing all 2 results
AB-PINACA is an exacerbate that was first distinguished as a part of manufactured cannabis items in Japan in 2012. It was initially created by Pfizer in 2009 as a pain relieving drug
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB₁ receptor and CB₂ receptor and fully substitutes for Δ⁹-THC in rat discrimination studies, while being 16x more potent.